Live Breaking News & Updates on Sarah Nikiforow

Stay updated with breaking news from Sarah nikiforow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Discovery may lead to expanded donor pool for stem cell transplants for patients with cancer

Discovery may lead to expanded donor pool for stem cell transplants for patients with cancer
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Harvard University , United States , Dana Farber Cancer Institute , H Moses Murdock , Lukaszp Gondek , Mark Fleharty , Christopherj Gibson , Tyler Dougan , Bin Chen , Elin Zhao , Madeleine Duran , Niallj Lennon , Junko Tsuji , Amye Dezern , Brendan Blumenstiel , R Coleman Lindsley , Richardj Jones , Haesookt Kim , Sarah Nikiforow , Jerome Ritz , Davidr Walt , Shiyu Wang , Carrie Cibulskis , Bryan Hambley , Christopherd Gocke , Robertj Soiffer ,

Repertoire Immune Medicines and Dana-Farber Cancer Institute Collaborate to Identify Novel Antigen Targets Within HPV+ Head and Neck Cancers


Press release content from Business Wire. The AP news staff was not involved in its creation.
Repertoire Immune Medicines and Dana-Farber Cancer Institute Collaborate to Identify Novel Antigen Targets Within HPV+ Head and Neck Cancers
February 11, 2021 GMT
Anthony Coyle, Ph.D., President, Research and Development, Repertoire Immune Medicines (Photo: Business Wire)
CAMBRIDGE, Mass. (BUSINESS WIRE) Feb 11, 2021
Repertoire Immune Medicines, a clinical-stage biotech company creating a new category of immune therapies for cancer, autoimmunity and infectious disease, today announced a research collaboration with Dana-Farber Cancer Institute to advance discovery and clinical development in human papillomavirus-positive (HPV+) oropharyngeal (head and neck) cancers. Through this collaboration, Dana-Farber and Repertoire aim to identify novel tumor antigen targets relevant to HPV+ head and neck tumors that will be used to inform the development of novel therapeutic cand ....

United Kingdom , Dana Farber Cancer Institute , United States , Ann Marie Egloff , Glenn Hanna , Carlo Tanzi , Lindsayg Deefholts , Sarah Nikiforow , Anthony Coyle , Ravindra Uppaluri , Department Of Surgery , Immune Medicines , Repertoire Immune Medicines , Business Wire , Rare Head , Neck Cancers , Neck Surgical Oncology , Lead Investigator , Medical Oncology , Study Identifier Number , Media Contact , Products And Services , Product Testing , Diagnosis And Treatment , Hpv Infections , Sexually Transmitted Diseases ,